NasdaqGS - Nasdaq Real Time Price USD
Zymeworks Inc. (ZYME)
12.16
+0.41
+(3.49%)
At close: April 22 at 4:00:01 PM EDT
12.16
0.00
(0.00%)
After hours: April 22 at 4:30:40 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 8 | 7 |
| Avg. Estimate | -0.73 | -0.47 | -1.7 | -1.35 |
| Low Estimate | -2.61 | -0.59 | -2.36 | -1.85 |
| High Estimate | -0.15 | -0.35 | -1.09 | -0.08 |
| Year Ago EPS | -0.42 | -0.49 | -1.62 | -1.7 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 7 | 7 |
| Avg. Estimate | 20.65M | 18.02M | 94.41M | 149.03M |
| Low Estimate | 8.6M | 8.6M | 53.2M | 46.4M |
| High Estimate | 40M | 27M | 126M | 313.26M |
| Year Ago Sales | 10.03M | 19.24M | 76.3M | 94.41M |
| Sales Growth (year/est) | 105.92% | -6.34% | 23.73% | 57.86% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.29 | -0.31 | -0.41 | -0.09 |
| EPS Actual | -0.42 | -0.49 | -0.39 | -0.31 |
| Difference | -0.13 | -0.18 | 0.02 | -0.22 |
| Surprise % | -43.84% | -58.92% | 4.53% | -236.23% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.73 | -0.47 | -1.7 | -1.35 |
| 7 Days Ago | -0.74 | -0.47 | -1.73 | -1.3 |
| 30 Days Ago | -0.44 | -0.42 | -1.75 | -1.16 |
| 60 Days Ago | -0.38 | -0.33 | -1.74 | -1.18 |
| 90 Days Ago | -0.38 | -0.33 | -1.74 | -1.18 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 4 | 2 |
| Up Last 30 Days | 3 | 2 | 5 | 2 |
| Down Last 7 Days | 2 | 2 | 2 | 3 |
| Down Last 30 Days | 1 | 2 | 1 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZYME | -73.88% | 4.08% | -5.00% | 20.92% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Initiated | LifeSci Capital: Outperform | 3/11/2025 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 3/10/2025 |
| Maintains | Citigroup: Buy to Buy | 3/7/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 12/19/2024 |
| Upgrade | JP Morgan: Neutral to Overweight | 12/16/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/22/2024 |
Related Tickers
ANAB AnaptysBio, Inc.
21.58
+4.66%
BCYC Bicycle Therapeutics plc
8.73
+16.24%
CGEM Cullinan Therapeutics, Inc.
8.37
+3.33%
JAZZ Jazz Pharmaceuticals plc
103.38
+3.03%
CNTA Centessa Pharmaceuticals plc
12.67
+4.28%
PRTA Prothena Corporation plc
9.54
+2.58%
SNDX Syndax Pharmaceuticals, Inc.
12.92
+8.30%
IGMS IGM Biosciences, Inc.
1.4600
+14.06%
VALN Valneva SE
6.81
+1.34%
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%